Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tandem Diabetes Care Inc shares valued at $941,400 were sold by BLICKENSTAFF KIM D on Nov 21 ’24. At $31.38 per share, BLICKENSTAFF KIM D sold 30,000 shares. The insider’s holdings dropped to 165,190 shares worth approximately $5.16 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, BLICKENSTAFF KIM D sold 10,000 shares, netting a total of over 300,000 in proceeds. Following the sale of shares at $30.00 each, the insider now holds 195,190 shares.
Before that, BLICKENSTAFF KIM D had added 30,000 shares to its account. In a trade valued at $900,000, the Board of Directors, Chair Emer bought Tandem Diabetes Care Inc shares for $30.00 each.
As published in their initiating research note from Bernstein on November 06, 2024, Tandem Diabetes Care Inc [TNDM] has been an Outperform and the price target has been revised to $42. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in early October. As of October 02, 2024, RBC Capital Mkts has initiated its “an Outperform” rating for TNDM. Earlier on August 22, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Equal-weight” for TNDM stock.
Analyzing TNDM Stock Performance
During the last five days, there has been a surge of approximately 3.55%. Over the course of the year, Tandem Diabetes Care Inc shares have jumped approximately 5.54%. Shares of the company reached a 52-week high of $53.69 on 05/31/24 and a 52-week low of $21.85 on 01/31/24. A 50-day SMA is recorded $35.42, while a 200-day SMA reached $38.26. Nevertheless, trading volume fell to 0.82 million shares from 1.32 million shares the previous day.
Support And Resistance Levels for Tandem Diabetes Care Inc (TNDM)
According to the 24-hour chart, there is a support level at 30.58, which, if violated, would cause prices to drop to 29.94. In the upper region, resistance lies at 31.59. The next price resistance is at 31.96. RSI (Relative Strength Index) is 47.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.65, which suggests the price will decrease in the coming days. Percent R is at 40.32%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
